Literature DB >> 8305648

Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error.

J T Daugirdas1.   

Abstract

The original formula proposed to estimate variable-volume single-pool (VVSP) Kt/V was Kt/V = -In(R - 0.008 * t - f * UF/W), where in the Kt/V range of 0.7 to 1.3, f = 1.0 (* denotes multiplication). This formula tends to overestimate Kt/V as the Kt/V increases above 1.3. Because higher Kt/V values are now commonly delivered, the validity of both the urea generation term (0.008 * f) and correction for UF/W were explored by solving VVSP equations for simulated hemodialysis situations, with Kt/V ranging from 0.6 to 2.6. The analysis led to the development of a second-generation formula, namely: Kt/V = -In(R - 0.008 * t) + (4-3.5 * R) * UF/W. The first and second generation formulas were then used to estimate the modeled VVSP Kt/V in 500 modeling sessions in which the Kt/V ranged widely from 0.7 to 2.1. An analysis of error showed that this second-generation formula eliminated the overestimation of Kt/V in the high ranges found with the first-generation formula. Also, total error (absolute value percent error + 2 SD) was reduced with the second-generation formula. These results led to the proposal of a new formula that can be used for a very wide range of delivered Kt/V.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305648     DOI: 10.1681/ASN.V451205

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  256 in total

1.  Whole body urea kinetics.

Authors:  J Sternby
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.

Authors:  P Carmichael; J Popoola; I John; P E Stevens; A R Carmichael
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

3.  Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors.

Authors:  Rui Dong; Zhi-Yong Guo
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

4.  Validation of the KDQOL-SF: a dialysis-targeted health measure.

Authors:  J C Korevaar; M P Merkus; M A M Jansen; F W Dekker; E W Boeschoten; R T Krediet
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

5.  Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients.

Authors:  Alicia M Neu; Barbara A Fivush; Bradley A Warady; Sandra L Watkins; Aaron L Friedman; Andrew S Brem; Stuart Goldstein; Diane L Frankenfield
Journal:  Pediatr Nephrol       Date:  2003-08-12       Impact factor: 3.714

6.  Use of Self-Organizing Maps for Balanced Scorecard analysis to monitor the performance of dialysis clinic chains.

Authors:  Isabella Cattinelli; Elena Bolzoni; Carlo Barbieri; Flavio Mari; José David Martin-Guerrero; Emilio Soria-Olivas; José Maria Martinez-Martinez; Juan Gomez-Sanchis; Claudia Amato; Andrea Stopper; Emanuele Gatti
Journal:  Health Care Manag Sci       Date:  2011-11-15

7.  Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.

Authors:  Emre Erdem
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  Perioperative hyperkalemia in hemodialysis patients undergoing parathyroidectomy for renal hyperparathyroidism.

Authors:  Guang Yang; Jing Wang; Jie Sun; Xiaoming Zha; Ningning Wang; Changying Xing
Journal:  Intern Emerg Med       Date:  2019-01-16       Impact factor: 3.397

9.  Dose of hemodialysis and survival: a marginal structural model analysis.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; Jongha Park; Onyebuchi A Arah; Steven M Brunelli; Allen R Nissenson; Daniel Gillen; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2014-04-26       Impact factor: 3.754

10.  Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers.

Authors:  Halil İbrahim Erdoğdu; Eray Atalay; Gül Gürsoy; Başol Canbakan; Serkan Aktürk; Canan Yazıcı; Orhan Yücel; Sinan Mersin; Sengül Üçer; Özgür Merhametsiz; Can Öner; Merve Erat
Journal:  Clin Exp Nephrol       Date:  2018-11-28       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.